6505-- Pegfilgrastim
ID: 36E79725R0001Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/ea0fdc4d1d304ed1be12e75c8351b3ce/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) numbered 36E79725R0001 for the procurement of Pegfilgrastim, aimed at ensuring a continuous supply for various entities including VA facilities, Consolidated Mail Order Pharmacies, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will be awarded to a responsible offeror capable of providing Pegfilgrastim with a unique National Drug Code (NDC) and adhering to strict labeling guidelines, prohibiting the affixing of new labels over existing ones. The estimated annual requirement is for 8,458 syringes across multiple variants, with the RFP expected to be released electronically around November 5, 2024, and responses due by November 19, 2024. Interested parties should monitor sam.gov for updates and direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.

    Point(s) of Contact
    Matthew PoulinContract Specialist
    (708) 786-5186
    Matthew.Poulin@va.gov
    Files
    Title
    Posted
    36E79725R0001_1.docx
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) numbered 36E79725R0001 for the procurement of Pegfilgrastim. This unrestricted contract aims to ensure a continuous supply of Pegfilgrastim for various entities including VA facilities, Consolidated Mail Order Pharmacies, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The successful contractor will be awarded a one-year contract with four additional one-year options. Offerors are required to provide Pegfilgrastim with a specific unique National Drug Code (NDC) and adhere to labeling guidelines prohibiting the affixing of new labels over existing ones. The expected annual requirement for Pegfilgrastim is specified at 8,458 syringes, across multiple unique variants. The RFP is slated for electronic release around November 5, 2024, with responses due by November 19, 2024. Interested parties should monitor sam.gov for updates and should direct inquiries to the points of contact provided.
    Lifecycle
    Title
    Type
    6505-- Pegfilgrastim
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for a contract to supply Calcitonin gene-related peptides (CGRP) as part of its Pharmaceutical Prime Vendor (PPV) Program. The procurement aims to establish a reliable source of these pharmaceutical products, ensuring compliance with federal regulations, including the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). This initiative is crucial for maintaining consistent supply and quality control across VA medical facilities. Interested offerors must submit their proposals by October 31, 2024, at 2:30 PM CT, and can direct inquiries to Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov.
    6505--Lamotrigine Immediate Release (IR) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Lamotrigine Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care facilities, including the Department of Defense and the Bureau of Prisons. The contract will cover an unrestricted procurement for multiple strengths and packaging sizes of Lamotrigine IR Tablets, with specific requirements for labeling and packaging to ensure compliance with safety standards. This procurement is critical for maintaining the availability of essential medications for veterans and other federal beneficiaries. Interested offerors should note that the solicitation is expected to be released on or about November 7, 2024, with a closing date of November 21, 2024; inquiries can be directed to Contract Specialist Ray Roldan at raymond.roldan@va.gov or by phone at 708-786-4930.
    6505--Tadalafil Tablets (VA-24-00107372)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79724R0033 concerning the procurement of Tadalafil Tablets, intended for various federal entities, including the Department of Defense and the Bureau of Prisons. The selected contractor will be responsible for ensuring a continuous supply of Tadalafil, with a contract period of one year and four optional annual extensions, and must adhere to specific labeling and packaging requirements, including safety features for the bottles. This procurement is crucial for meeting the medication needs of veterans and other federal healthcare programs, with an estimated total annual requirement of approximately 322,854 bottles across various strengths. Interested parties should direct inquiries to Contract Specialist Billy Fong at billy.fong@va.gov, and proposals are due by November 12, 2024, following the RFP release on or about October 29, 2024.
    6505--Aspirin_Dipyridamole SA Capsules (VA-25-00011491)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Aspirin 25 MG/Dipyridamole 200MG Sustained Action (SA) Capsules under solicitation number 36E79724R0034. The contract aims to establish a reliable supply source for these pharmaceuticals, which will be utilized by the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service, with an estimated annual requirement of 37,545 bottles. The contract will span one year with four optional one-year extensions, and interested offerors must submit their proposals electronically by the closing date of November 29, 2024. For further inquiries, potential bidders can contact Contract Specialist Youlanda Duggar at Youlanda.Duggar@va.gov or by phone at 708-786-4943.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Betamethasone RFP
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Betamethasone Dipropionate Cream, a pharmaceutical product essential for the healthcare of veterans. Offerors are required to submit competitive pricing for a base year and four option years, including a mandatory 0.5% Cost Recovery Fee, while ensuring compliance with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is vital for maintaining a consistent supply of medications through the VA and Department of Defense's Prime Vendor Programs, emphasizing the government's commitment to providing quality healthcare to service members. Interested vendors should contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further details regarding the solicitation.
    770-25-1-801-0016 -National CMOP NALTREXONE -(VA-25-00010070)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Naltrexone tablets as part of a procurement initiative under solicitation number 36C77025Q0036. Vendors are required to submit their quotes by 4:00 PM CT on October 28, 2024, and must include essential documentation such as a signed SF1449 Solicitation cover page, a completed quote spreadsheet, and compliance with the Drug Supply Chain Security Act. This procurement is critical for ensuring the availability of pharmaceuticals necessary for the healthcare of veterans, reflecting the government's commitment to quality service. Interested vendors can contact Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162 for further information.
    6550--VA Northern California Health Care System, Mather Radiopharmaceuticals & Radiopharmaceutical Supplies
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the provision of radiopharmaceuticals and related supplies for the VA Northern California Health Care System, specifically under solicitation number 36C26124Q0846. The contract will cover five ordering periods from April 1, 2025, to March 31, 2030, and requires contractors to deliver various radiopharmaceuticals while adhering to regulatory standards set by the Nuclear Regulatory Commission and the Food and Drug Administration. This procurement is crucial for ensuring reliable access to essential medical isotopes, which are vital for healthcare services provided to veterans. Interested contractors must submit their offers by October 28, 2024, at 12 PM PDT, and can direct inquiries to Contract Specialist Tawnya S Krommenhoek at tawnya.krommenhoek@va.gov. The contract has a minimum guaranteed value of $100 and a maximum total order value of $2.5 million.
    Repaglinide
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Repaglinide Tablets. The contract will establish a national supply source for the purchase of Repaglinide 0.5MG, 1MG, and 2MG in 100 count bottles. This acquisition will be unrestricted and fully competitive. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The items listed in the schedule will be purchased by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. Interested parties should contact Phyllis Daraio for any questions/comments. The projected solicitation date is September 2020.
    Q517--Omnicell New Preventative Maintenance Service Package
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) Network Contracting Office 19 intends to award a sole source Fixed Price Indefinite Delivery/Indefinite Quantity (ID/IQ) contract to Omnicell, INC. for the provision of preventative maintenance and support for the Omnicell Medication Supply Station and System. This contract will include enhancements such as the addition of new software and capabilities, ensuring the operational efficiency of the medication dispensing systems critical to healthcare services. Interested firms may submit written notifications demonstrating their ability to meet the requirements by November 14, 2024, at 10:00 AM Mountain Standard Time, with all responses directed to Contract Specialist David Glanton at david.glanton@va.gov. Contractors must be registered in the System for Award Management (SAM) to be eligible for consideration, and the estimated period of performance for this contract is from February 1, 2025, to January 31, 2028.